Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Type of respiration observed in morphine poisoning is:

Slow. **Explanation:** The hallmark of opioid toxicity, including morphine poisoning, is **central nervous system and respiratory depression**. Morphine acts primarily on the **mu (μ) opioid receptors** located in the brainstem respiratory centers. This stimulation leads to a direct reduction in the responsiveness of the respiratory center to carbon dioxide (CO2) levels. Consequently, the respiratory rate decreases significantly, often falling to 2–4 breaths per minute. This is clinically described as **slow and shallow breathing**. **Analysis of Options:** * **A. Slow (Correct):** Morphine depresses the rhythmicity and sensitivity of the medullary respiratory center, leading to a marked decrease in respiratory rate (bradypnea). * **B. Rapid:** Rapid breathing (tachypnea) is characteristic of stimulants or conditions like salicylate poisoning, where the respiratory center is directly stimulated. * **C. Rapid shallow:** This pattern is often seen in restrictive lung diseases or pleuritic pain, but not in opioid overdose. * **D. Diaphragmatic:** While breathing may become primarily diaphragmatic if intercostal muscles are affected, the defining characteristic of morphine poisoning is the rate (slowness), not the muscle group used. **High-Yield Clinical Pearls for NEET-PG:** * **The Classic Triad of Morphine Poisoning:** 1. Respiratory depression (Slow breathing), 2. Pinpoint pupils (Miosis), and 3. Coma/Altered sensorium. * **Exception to Miosis:** In severe hypoxia or Pethidine (Meperidine) overdose, pupils may be dilated (mydriasis). * **Specific Antagonist:** **Naloxone** is the drug of choice for reversing respiratory depression. * **Cause of Death:** Respiratory failure is the most common cause of death in acute opioid overdose.

Q: What is true about thalidomide?

It ameliorates cancer-associated cachexia.. **Explanation:** **Thalidomide** is a multifaceted drug originally used as a sedative, famously withdrawn due to severe teratogenicity (phocomelia), and later repurposed for its potent immunomodulatory and anti-angiogenic properties. **Why Option C is correct:** Thalidomide is a potent **inhibitor of Tumor Necrosis Factor-alpha (TNF-α)**, also known as "cachectin." TNF-α is the primary cytokine responsible for the profound weight loss, muscle wasting, and anorexia seen in advanced malignancies. By suppressing TNF-α production, thalidomide helps **ameliorate cancer-associated cachexia**, improving the quality of life in palliative care settings. **Analysis of Incorrect Options:** * **Option A:** While thalidomide has anti-angiogenic properties, it has shown disappointing results in most **solid tumors**. Its primary oncological success is in **Multiple Myeloma** (where it is a first-line agent along with dexamethasone). * **Option B:** Thalidomide does **not** have direct antileprotic (antimicrobial) action against *M. leprae*. Instead, it is the drug of choice for **Erythema Nodosum Leprosum (ENL)**, a Type 2 lepra reaction. It treats the *complication* of leprosy, not the infection itself. **High-Yield NEET-PG Pearls:** 1. **Mechanism:** Inhibits TNF-α and inhibits angiogenesis by suppressing basic Fibroblast Growth Factor (bFGF) and Vascular Endothelial Growth Factor (VEGF). 2. **Clinical Uses:** Multiple Myeloma, ENL (Type 2 Lepra reaction), HIV-associated wasting/aphthous ulcers. 3. **Teratogenicity:** Causes **Phocomelia** (seal-like limbs). It is contraindicated in pregnancy (Category X). 4. **Side Effects:** Peripheral neuropathy (most common dose-limiting toxicity), sedation, and increased risk of thromboembolism (especially when combined with steroids).

Q: Urine alkalinization is beneficial in ameliorating the toxicity of which of the following drugs?

Methotrexate. **Explanation:** The correct answer is **Methotrexate**. **Mechanism of Action & Rationale:** Methotrexate (MTX) and its metabolites (specifically 7-hydroxymethotrexate) are poorly soluble in acidic environments. At a low urinary pH, MTX can precipitate in the renal tubules, leading to **crystalluria** and acute obstructive nephropathy. **Urine alkalinization** (using intravenous sodium bicarbonate to achieve a pH > 7.0) significantly increases the ionization and solubility of MTX, thereby facilitating its excretion and preventing renal toxicity. Vigorous hydration is also essential. **Analysis of Incorrect Options:** * **A. Cytarabine:** Its dose-limiting toxicity is primarily hematological (bone marrow suppression) and cerebellar ataxia at high doses. It does not cause renal crystal formation. * **B. Ifosfamide:** While it causes hemorrhagic cystitis (due to the metabolite acrolein), the standard preventive measure is **MESNA** and hydration, not urine alkalinization. * **C. Cisplatin:** Its primary toxicity is acute tubular necrosis. Prevention involves aggressive hydration with **normal saline** and sometimes osmotic diuresis (Mannitol), but alkalinization does not specifically mitigate its nephrotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Urine Alkalinization** is also used for toxicities of **Salicylates (Aspirin)** and **Phenobarbital** (weakly acidic drugs). * **Urine Acidification** (using Ammonium Chloride) was historically used for weak bases like Amphetamines, but is now rarely practiced due to the risk of systemic acidosis. * **Leucovorin (Folinic acid) Rescue** is used specifically for MTX toxicity to bypass the inhibited dihydrofolate reductase. * **Glucarpidase** is an enzyme used as an antidote for toxic MTX levels in patients with renal failure.

Q: Which immunosuppressant drug inhibits the action of IL-3 without inhibiting its transcription?

Sirolimus. ### Explanation The correct answer is **Sirolimus (Rapamycin)**. #### 1. Why Sirolimus is Correct The mechanism of action of Sirolimus involves binding to the intracellular protein **FKBP-12**. This complex inhibits the **mTOR (mammalian Target of Rapamycin)** pathway. Unlike calcineurin inhibitors, Sirolimus does not prevent the production (transcription) of cytokines like IL-2 or IL-3. Instead, it inhibits the **downstream signaling** and cellular response to these cytokines. Therefore, while IL-3 is produced normally, its action on T-cell proliferation is blocked. #### 2. Why Other Options are Incorrect * **Prednisolone:** Glucocorticoids act by inhibiting the expression of multiple inflammatory genes. They inhibit the **transcription** of various cytokines (IL-1, IL-2, IL-3, IL-6, TNF-α) by interfering with NF-κB signaling. * **Cyclosporine:** This is a **Calcineurin inhibitor**. It binds to Cyclophilin to inhibit calcineurin, preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This directly blocks the **transcription** of IL-2 and IL-3. * **Tacrolimus:** Similar to Cyclosporine, it is a **Calcineurin inhibitor** (though it binds to FKBP-12). It also prevents the **transcription** of IL-2 and IL-3. #### 3. High-Yield Clinical Pearls for NEET-PG * **Sirolimus Side Effect:** Notably causes **hyperlipidemia** (increased cholesterol and triglycerides) and **thrombocytopenia**. * **Kidney Sparing:** Unlike Cyclosporine and Tacrolimus, Sirolimus is **not nephrotoxic**, making it useful in patients with renal impairment. * **Drug-Eluting Stents:** Sirolimus is frequently used in coronary stents to prevent restenosis by inhibiting smooth muscle cell proliferation. * **Mnemonic:** **C**alcineurin inhibitors block **C**reation (transcription) of cytokines; **S**irolimus blocks **S**ignaling (action) of cytokines.

Q: Which of the following is NOT useful for the management of hypermagnesemia?

Amiloride. Hypermagnesemia (Serum $Mg^{2+} > 2.5$ mg/dL) is a rare but life-threatening electrolyte imbalance, usually occurring in patients with renal failure or those receiving excessive magnesium therapy (e.g., for eclampsia). **Why Amiloride is the Correct Answer:** Amiloride is a **potassium-sparing diuretic** that works by inhibiting the Epithelial Sodium Channels (ENaC) in the distal tubule [2]. Importantly, amiloride and other potassium-sparing diuretics (like triamterene) actually **decrease the excretion of magnesium**. Using amiloride would worsen hypermagnesemia, making it contraindicated in this condition. **Analysis of Incorrect Options:** * **Calcium Gluconate:** This is the **first-line emergency treatment**. Calcium acts as a direct physiological antagonist to magnesium at the neuromuscular junction and cardiac membrane, reversing life-threatening respiratory depression or arrhythmias. * **Intravenous Fluids:** Normal saline (0.9% NaCl) combined with **loop diuretics** (like Furosemide) is used to promote "forced diuresis." This increases the renal clearance of magnesium in patients with preserved renal function [1]. * **Magnesium-free Enema:** In cases of magnesium ingestion (e.g., laxative overdose), removing unabsorbed magnesium from the GI tract using magnesium-free solutions or enemas helps prevent further systemic absorption. **NEET-PG High-Yield Pearls:** 1. **Clinical Presentation:** Loss of deep tendon reflexes (DTRs) is the earliest sign ($7–10$ mEq/L), followed by respiratory paralysis and cardiac arrest ($>12$ mEq/L). 2. **Antidote:** IV Calcium Gluconate (10%) is the specific antidote for magnesium toxicity. 3. **Renal Failure:** In patients with severe renal impairment and symptomatic hypermagnesemia, **hemodialysis** is the definitive management. 4. **Drug Association:** Loop diuretics (Furosemide) *increase* Mg excretion [1], while Potassium-sparing diuretics (Amiloride) *decrease* it.

Q: Thalidomide is used in which of the following conditions?

All of the above. Thalidomide, once infamous for its teratogenic effects (phocomelia), has been repurposed in modern medicine due to its potent **anti-inflammatory, immunomodulatory, and anti-angiogenic** properties. It acts primarily by inhibiting Tumor Necrosis Factor-alpha (TNF-α) and modulating T-cell responses. **Explanation of Options:** * **Lepra Reaction (ENL):** Thalidomide is the drug of choice for Type 2 Lepra Reaction (Erythema Nodosum Leprosum). It effectively suppresses the systemic inflammatory response by inhibiting TNF-α. * **Multiple Myeloma:** It is a cornerstone in the treatment of refractory or newly diagnosed Multiple Myeloma. Its mechanism involves inhibiting angiogenesis in the bone marrow and inducing apoptosis of malignant plasma cells. * **Ulcerative Colitis:** Due to its TNF-α inhibitory action, thalidomide is used as an "off-label" or reserve treatment for refractory cases of Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn’s disease, when standard therapies fail. **Clinical Pearls for NEET-PG:** 1. **Mechanism:** Inhibition of TNF-α and IL-12; stimulation of T-cells (CD8+); and anti-angiogenic activity (via inhibition of VEGF and bFGF). 2. **Teratogenicity:** It is a category X drug. It causes **Phocomelia** (seal-like limbs) by inhibiting angiogenesis in developing limb buds. 3. **STEPS Program:** Due to its high teratogenic risk, it is prescribed under a restricted distribution program (System for Thalidomide Education and Prescribing Safety). 4. **Side Effects:** Peripheral neuropathy (most common dose-limiting toxicity), sedation, and increased risk of venous thromboembolism (especially when used with dexamethasone in Myeloma).

Q: A 50-year-old male, suffering from renal failure, underwent a kidney transplant and was prescribed a nucleotide derivative post-transplant. Which nucleotide derivative is of therapeutic importance in this organ transplant?

Azathioprine. **Explanation:** The correct answer is **Azathioprine**. **Why Azathioprine is correct:** Azathioprine is a prodrug that is non-enzymatically converted into **6-mercaptopurine (6-MP)**, a purine analogue (nucleotide derivative). It acts as an immunosuppressant by inhibiting purine synthesis, which specifically prevents the proliferation of T and B lymphocytes. In the context of organ transplantation (like the kidney transplant mentioned), it is used to prevent **acute graft rejection** by suppressing the recipient's immune response against the donor organ. **Analysis of Incorrect Options:** * **5-Fluorouracil (5-FU):** This is a pyrimidine analogue used primarily as a cytotoxic chemotherapy agent for solid tumors (e.g., colorectal cancer), not for immunosuppression in transplants. * **Cytarabine (Ara-C):** This is also a pyrimidine analogue (cytosine arabinoside) used mainly in the treatment of hematological malignancies like Acute Myeloid Leukemia (AML). * **Allopurinol:** While it is a purine analogue, it is a **xanthine oxidase inhibitor** used to treat gout and hyperuricemia. It is not an immunosuppressant. **NEET-PG High-Yield Pearls:** * **Drug Interaction:** Allopurinol inhibits xanthine oxidase, the enzyme responsible for metabolizing 6-MP. If a patient on Azathioprine is given Allopurinol, the levels of 6-MP rise significantly, leading to severe **bone marrow toxicity**. The dose of Azathioprine must be reduced by 75% in such cases. * **Pharmacogenomics:** Patients with a genetic deficiency of the enzyme **TPMT (Thiopurine Methyltransferase)** are at high risk of life-threatening myelosuppression when taking Azathioprine. * **Side Effects:** The most common side effect is bone marrow suppression (leukopenia).

Q: Which of the following is NOT an ototoxic drug?

Atropine. **Explanation:** The correct answer is **Atropine**. Atropine is an anticholinergic drug used to decrease secretions and treat bradycardia; it has no known vestibulocochlear toxicity. **Why the other options are Ototoxic:** * **Streptomycin:** An aminoglycoside antibiotic that is primarily **vestibulotoxic**. It selectively damages the sensory hair cells of the crista ampullaris, leading to vertigo and imbalance. * **Vancomycin:** A glycopeptide antibiotic that can cause **cochleotoxicity** (sensorineural hearing loss), especially when administered in high doses, in patients with renal failure, or when used synergistically with aminoglycosides. * **Furosemide:** A loop diuretic that causes ototoxicity by altering the ionic composition of the endolymph in the **stria vascularis**. It typically causes temporary hearing loss, though it can be permanent in high doses. **High-Yield Clinical Pearls for NEET-PG:** 1. **Aminoglycoside Selectivity:** * **Vestibulotoxic:** Streptomycin and Gentamicin (Mnemonic: **S**top **G**oing). * **Cochleotoxic:** Amikacin, Neomycin, and Kanamycin (Mnemonic: **A**ll **N**ew **K**ids). 2. **Salicylates (Aspirin):** Characteristically cause **reversible** SNHL and high-pitched tinnitus. 3. **Cisplatin:** A common chemotherapeutic agent that causes bilateral, symmetrical, high-frequency permanent hearing loss. 4. **Thalidomide:** A known teratogen that can cause external ear anomalies (microtia/anotia) if taken during pregnancy.

Q: Methemoglobinemia may be caused by the following agents, EXCEPT:

Phenytoin. **Explanation:** **Methemoglobinemia** occurs when the iron in hemoglobin is oxidized from the ferrous state ($Fe^{2+}$) to the **ferric state ($Fe^{3+}$)**. Ferric iron cannot bind oxygen, and it also increases the oxygen affinity of the remaining ferrous heme, leading to a leftward shift of the oxygen-dissociation curve and tissue hypoxia. **Why Phenytoin is the Correct Answer:** **Phenytoin** is an antiepileptic drug primarily associated with side effects like gingival hyperplasia, hirsutism, megaloblastic anemia (due to folate deficiency), and Stevens-Johnson Syndrome. It **does not** possess the oxidative potential required to convert hemoglobin to methemoglobin. **Analysis of Incorrect Options (Agents that cause Methemoglobinemia):** * **Sulfonamides:** These are classic oxidizing agents. They induce oxidative stress on red blood cells, leading to methemoglobin formation, especially in individuals with G6PD deficiency. * **Phenacetin:** An older analgesic (now largely withdrawn) known for causing nephropathy and oxidative hemolysis/methemoglobinemia. * **Phenazopyridine:** Used as a urinary analgesic, it is a potent oxidizing agent that can cause methemoglobinemia even in therapeutic doses, particularly in patients with renal impairment. **High-Yield Clinical Pearls for NEET-PG:** 1. **Clinical Presentation:** Patients present with "Chocolate-colored blood" and central cyanosis that does not improve with 100% oxygen. 2. **Antidote:** The drug of choice is **Methylene Blue** (acts as an electron acceptor for NADPH-methemoglobin reductase). 3. **Other Common Triggers:** Nitrites/Nitrates, Local anesthetics (Prilocaine, Benzocaine), Dapsone, and Nitrofurantoin. 4. **Diagnosis:** A "Saturation Gap" is often seen (difference between $SaO_2$ on pulse oximetry and $SaO_2$ on ABG).

Question 1

Type of respiration observed in morphine poisoning is:

Accepted Answer

Slow

Answer

Rapid

Answer

Rapid shallow

Answer

Diaphragmatic

Question 2

Which of the following is NOT given to prevent rejection in organ transplantation?

Accepted Answer

Hyperimmune sera

Answer

Steroids

Answer

T cell inhibitors

Answer

Azathioprine

Question 3

What is true about thalidomide?

Accepted Answer

It ameliorates cancer-associated cachexia.

Answer

It exerts antitumour activity in some solid malignant tumours.

Answer

It exerts antileprotic action.

Answer

All of the above.

Question 4

Urine alkalinization is beneficial in ameliorating the toxicity of which of the following drugs?

Accepted Answer

Methotrexate

Answer

Cytarabine

Answer

Ifosfamide

Answer

Cisplatin

Question 5

Which immunosuppressant drug inhibits the action of IL-3 without inhibiting its transcription?

Accepted Answer

Sirolimus

Answer

Prednisolone

Answer

Cyclosporine

Answer

Tacrolimus

Question 6

Which of the following is NOT useful for the management of hypermagnesemia?

Accepted Answer

Amiloride

Answer

Magnesium-free enema

Answer

Intravenous fluids

Answer

Calcium gluconate

Question 7

Thalidomide is used in which of the following conditions?

Accepted Answer

All of the above

Answer

Lepra reaction

Answer

Multiple Myeloma

Answer

Ulcerative Colitis

Question 8

A 50-year-old male, suffering from renal failure, underwent a kidney transplant and was prescribed a nucleotide derivative post-transplant. Which nucleotide derivative is of therapeutic importance in this organ transplant?

Accepted Answer

Azathioprine

Answer

5-Fluorouracil

Answer

Cytarabine

Answer

Allopurinol

Question 9

Which of the following is NOT an ototoxic drug?

Accepted Answer

Atropine

Answer

Streptomycin

Answer

Vancomycin

Answer

Furosemide

Question 10

Methemoglobinemia may be caused by the following agents, EXCEPT:

Accepted Answer

Phenytoin

Answer

Sulfonamides

Answer

Phenacetin

Answer

Phenazopyridine

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?